ARIEL HATTEN: Open Payments
NPI 1831826346 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 7 payments from 6 companies in 2025. Trend: 2023 $311 · 2024 $140 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $35 |
| Amgen Inc. | 2 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| SCPHARMACEUTICALS INC. | 1 | $19 |
Products named: ONPATTRO, REPATHA, LEQVIO, Kerendia, JARDIANCE, FUROSCIX.
Industry payments across FL — which companies pay providers there.
